Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Direct Deal between Makers, Med. Institutions Conditionally Approvable: Mr Katagiri of FTC
September 4, 2006
- MEDICAL DEVICE NEWS IN BRIEF
September 4, 2006
- Blopress Top-selling Drug in April-June: IMS Japan
September 4, 2006
- SELF-MEDICATION NEWS IN BRIEF
September 4, 2006
- Cook's Zenith Endograft Approved
August 28, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 28, 2006
- MEDICAL DEVICE NEWS IN BRIEF
August 28, 2006
- MPC Working Hard to Become a "Muscular" Company: President Komine
August 28, 2006
- Stem Cells Resembling ES Cells Induced from Mouse Skin Cells
August 28, 2006
- PI Forum Helps Member Companies Embark on New Businesses: Mr Ohyagi
August 28, 2006
- R&D NEWS IN BRIEF
August 28, 2006
- BUSINESS NEWS IN BRIEF
August 28, 2006
- NEW PRODUCTS
August 28, 2006
- COMMENTARY／Korosho Gets Involved to Eliminate Provisional Delivery
August 28, 2006
- Drug Development Beyond Borders -Today's Global Cooperative Clinical Trials-
August 28, 2006
- Drug Firms Should Support Job Sharing between Regional Med. Institutions: Mr Matsubara
August 28, 2006
- Use of Generic Drugs Increasing at Tokyo Municipal Hospitals
August 28, 2006
- Drug Makers Actively Outsourcing to India: MediBic
August 28, 2006
- Doctors Object to Generics Use Promotion Service
August 28, 2006
- STOP PRESS／Schering-Plough Withdraws NDA for Garenoxacin It Submitted to FDA
August 28, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…